At a time when children and families are increasingly in need of mental health support, Evernorth Health Group said it will offer behavioral health provider Brightline’s services to its employer clients.
The two companies announced…
Eli Lilly is cutting insulin prices, and this time it’s for real.
Months after a Twitter account posing as the drugmaker went viral with a tweet stating, “insulin is free now,” the company on Wednesday…
By Hannah Nelson
March 01, 2023 – The Puerto Rico Health Information Exchange (PRHIE) has announced its intention to participate in TEFCA through Health Gorilla’s anticipated Qualified Health Information Network (QHIN).
Health Gorilla is a…
Friedrich’s ataxia, an ultra-rare disease that causes progressively worsening muscle function that ultimately leads to death, now has its first FDA-approved therapy. The regulator has given the green light to a Reata Pharmaceuticals drug…
Continue Reading
Are you thinking of starting an online pharmacy delivery business? Here are 5 compelling reasons to help you decide!1. High-demand industry and high earning potential2. Low barrier to entry3. Constant profits once you set…
Continue Reading
Israel-based AION Labs, an AI-enabled drug discovery partnership between global pharma and tech companies, announced the launch of its second startup, DenovAI.DenovAI will develop an AI-enabled computational biophysics platform that can discover potential antibodies…
Continue Reading
Aptinyx’s approach of treating neurological disorders by targeting a key receptor in the brain has fallen short again, this time in Parkinson’s disease. With its third clinical trial failure in less than a year,…
Continue Reading
Generic drugs giant Dr. Reddy’s is acquiring the U.S portfolio of Mayne Pharma in a deal that includes a birth control pill Mayne has described as its most significant product opportunity.
Under deal terms announced…
Mark Diamond, Managing Director and CEO at Antisense Therapeutics Limited joins eHealth Radio and the Health News Channel. Antisense is an Australian publicly-listed biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet…
Continue Reading
A Fulcrum Therapeutics clinical trial testing a potential sickle cell disease drug has been paused by the FDA. With the clinical hold on the early-stage study, Fulcrum becomes the fourth company with a stalled…
Continue Reading
